← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Oscient Pharmaceuticals Corporation
Waltham, MA
$29,195,781
Total funding
8
Grants
Funding mix
By agency
NIH$29,195,781 · 8
By mechanism
U54$25,519,497 · 2
R44$2,176,226 · 4
R24$1,444,315 · 1
R43$55,743 · 1
Investigators at Oscient Pharmaceuticals Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
GTC SEQUENCING CENTER$7,335,882
U54 · FY2001 · HG
LARGE-SCALE SEQUENCING OF THE RAT GENOME$4,042,621
U54 · FY2002 · HG
LARGE-SCALE SEQUENCING OF THE RAT GENOME$3,589,693
U54 · FY2001 · HG
GTC SEQUENCING CENTER$3,307,953
U54 · FY2002 · HG
LARGE-SCALE SEQUENCING OF THE MOUSE GENOME$2,800,089
U54 · FY2000 · HG
GTC SEQUENCING CENTER$1,716,665
U54 · FY2000 · HG
LARGE-SCALE SEQUENCING OF THE RAT GENOME$1,469,999
U54 · FY2003 · HG
SYSTEMS FOR CAPILLARY-BASED SAMPLE HANDLING$746,682
R24 · FY2000 · HG
GTC SEQUENCING CENTER$681,170
U54 · FY2003 · HG
Integrated Methods to Discover Novel Disease Pathways$474,283
R44 · FY2004 · AG
LOW-COST, SEQUENCE-BASED CANCER PHARMACOGENETICS$449,844
R44 · FY2001 · CA
LOW-COST, SEQUENCE-BASED CANCER PHARMACOGENETICS$447,683
R44 · FY2000 · CA
LARGE-SCALE SEQUENCING OF THE RAT GENOME$358,971
U54 · FY2001 · HG
SYSTEMS FOR CAPILLARY-BASED SAMPLE HANDLING$355,747
R24 · FY2001 · HG
Flat Plates for Small Volume Thermocycling and Clean-up$341,886
R24 · FY2002 · HG
Effects of SNPs on Gene Regulation in Complex Diseases$332,580
R44 · FY2004 · GM
Integrated Methods to Discover Novel Disease Pathways$235,381
R44 · FY2003 · AG
Effects of SNPs on Gene Regulation in Complex Diseases$210,882
R44 · FY2003 · GM
LARGE-SCALE SEQUENCING OF THE RAT GENOME$145,200
U54 · FY2001 · HG
GTC SEQUENCING CENTER$71,254
U54 · FY2001 · HG